"Feed the World"
Enterprise: SenesTech, Inc. (SenesTech) is an early stage platform biotechnology company specializing in reproductive physiology. Its mission is to complete the development of non-surgical reproduction control technology that could profoundly increase food production throughout the world via rodent and wildlife population control. We are currently applying our revolutionary technology to the control of the Southeast Asian Rice Rat in order to increase rice production. We believe that with the application of our product, ContraPest™, we will be able to feed at least an additional 380 million people annually within three years. SenesTech is developing strategic partnerships with international industry partners, non-profit institutions, and universities to accelerate the translation of its platform technology into marketable products within 24 months.
Technology: SenesTech believes its technology is the first of its kind in the world. We are conducting cutting-edge research in mammalian female senescence and developing animal research models, advancing efforts in wildlife population control, and developing companion animal chemical spay technology. The technology is based on the development of species-specific protocols to chemically accelerate the natural depletion of the non-regenerating pool of primordial and primary follicles in the mammalian ovary, resulting in ovarian failure and sterility. The protocol has been refined and optimized to achieve follicle depletion without causing systemic toxicity or adverse side effects and is environmentally neutral.
Company Background: SenesTech was founded in 2002 in Flagstaff, Arizona and is based on technology licensed from the University of Arizona. It has recently entered into a strategic alliance with the government of Australia to service the needs of Australia, New Zealand, and Southeast Asia in rodent population control. Domestic and International patents are pending.
Management: Everett P. Hale is SenesTech’s Chief Executive Officer. Mr. Hale has extensive experience in management, operations and taking start-up companies to the IPO stage. Three scientists have been involved in the research that forms the basis of SenesTech’s platform technology. Loretta P. Mayer, Ph.D. has been the principal investigator in development of the pending patents for chemical sterilization of mammals, and serves as Chairman of the Board and President. Cheryl A. Dyer, Ph.D. is the principal investigator involved in application of the rodent model in collaborative studies, the lead scientist for development of commercial delivery of the technology for research purposes, and serves as Chief Scientific Officer. Timothy L. Vail, Ph.D. is the lead investigator for formulation and manufacturing of the end-stage products, and serves as Vice President. Roger Bollard, CPA is the Chief Financial Officer.
Market: Initial market analyses indicate a primary market in agriculture, with a secondary market in companion animal chemical spay. SenesTech’s rodent fertility control product ContraPest™ will replace the use of toxins in a world market that can suffer up to 33% crop losses due to rodent infestations. Annual sales are projected to supplant current poison products within three years with annual revenue in excess of $1 billion. A humane method for population control of wild animals such as deer, coyotes, foxes, raccoons, horses, buffalo, elk as well as feral dogs and cats represent potential follow-on market segments. At an international meeting of scientists in Washington DC in November 2006 ChemSpay™ was determined to be the only irreversible product in development that can adequately address the dog and cat overpopulation problems.
Products and Services: ContraPest™, which will be delivered via oral baiting, will be registered first in Australia and marketed to the Southeast Asian rice producing countries to address the immediate need of increased rice production to help alleviate world-wide famine. As a result of the bait development, the companion product will be sold in the US to support research animal sales by The Jackson Laboratory (JAX). The technology will then be expanded to other species and subsequently to address the overpopulation of feral dogs and cats worldwide as ChemSpay™.
Contact us: info@senestech.com